Abstract
Effective treatment of obstructive sleep apnoea (OSA) is primarily determined by adherence to the selected intervention. The most common treatment pathways are mechanical devices such as continuous positive airway pressure (CPAP) or a mandibular advancement device, often combined with weight loss therapy. Weight reduction is usually an adjunct therapy but may be used as a secondary treatment in mild-to-moderate OSA when mechanical treatments cannot be tolerated. To enhance the uptake and adherence to treatment, clinicians may assess patient's personality profiles and psychological readiness. There is a paucity of evidence related to these aspects of patient care and this article outlines the current research in relation to patient presentation, treatment uptake and barriers, and methods to enhance treatment adherence.
This article disseminates personality traits observed in patients with OSA and identifies vulnerable groups who may require additional support to increase treatment adherence. It summarises the current evidence for treatment barriers in patients with OSA. Low self-efficacy in relation to CPAP and weight loss adherence will be explored as well as the potential to predict treatment responders and enhance therapeutic uptake and adherence. Extending personality traits into research and clinical practice could potentially result in more successful CPAP therapy and weight loss treatment outcomes.
Abstract
Personality traits and self-efficacy requires assessment prior to commencing CPAP or weight loss therapy in the management of OSA. These important factors may enhance treatment adherence and require ongoing assessment. bit.ly/2Q5TVl9
Footnotes
Number 4 in the Series “Sleep Disordered Breathing” Edited by Renata Riha and Maria Bonsignore
Previous articles in this series: No. 1: Masa JF, Pepin J-L, Borel J-C, et al. Obesity hypoventilation syndrome. Eur Respir Rev 2019; 28: 180097. No. 2: Bruyneel M. Telemedicine in the diagnosis and treatment of sleep apnoea. Eur Respir Rev 2019; 28: 180093. No. : Ryan S, Arnaud A, Fitzpatrick SF, et al. Adipose tissue as a key player in obstructive sleep apnoea. Eur Respir Rev 2019; 28: 190006.
Provenance: Submitted article, peer reviewed.
Conflict of interest: E.A. Cayanan has nothing to disclose.
Conflict of interest: D.J. Bartlett has nothing to disclose.
Conflict of interest: J.L Chapman has nothing to disclose.
Conflict of interest: C.M. Hoyos has nothing to disclose.
Conflict of interest: C.L. Phillips has nothing to disclose.
Conflict of interest: R.R, Grunstein has nothing to disclose.
Support statement: E.A. Cayanan and J.L. Chapman receive funding through the National Health and Medical Research Council Centre of Research Excellence (NeuroSleep Sydney, NSW, Australia). R.R. Grunstein receives funding through a National Health and Medical Research Council Senior Principal Research Fellowship. C.L. Phillips receives funding through a National Health and Medical Research Council Boosting Dementia Research Leadership Fellowship and the Sydney Medical School Foundation Chapman Fellowship. C.M. Hoyos receives funding through a National Health and Medical Research Council – Australian Research Council Dementia Research Development Fellowship. Funding information for this article has been deposited with the Crossref Funder Registry.
- Received January 18, 2019.
- Accepted May 9, 2019.
- Copyright ©ERS 2019.
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
